Clinical Trials · NCT02220348
A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Forest Laboratories
- Enrollment
- 7
- Start date
- Jul 2014
- Locations
- 2 sites, United States
- Primary endpoint
- Amount of linaclotide and its active metabolite (MM-419447) excreted in breast milk